Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal.

Slides:



Advertisements
Similar presentations
The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Advertisements

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.
Curative Treatment of Stage I Non-Small-Cell Lung Cancer in Patients With Severe COPD: Stereotactic Radiotherapy Outcomes and Systematic Review  David.
COSMIC: A Regimen of Intensity Modulated Radiation Therapy Plus Dose-Escalated, Raster-Scanned Carbon Ion Boost for Malignant Salivary Gland Tumors: Results.
Pre-operative hyperfractionated radiotherapy and concurrent 5-fu/cisplatin for locally advanced esophageal cancer - the impact of 18-F-fluoro-deoxy-d-glucose.
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Cost-Effectiveness Analysis of Stereotactic Body Radiotherapy and Radiofrequency Ablation for Medically Inoperable, Early-Stage Non–Small Cell Lung Cancer 
18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy 
T. Liu, J. Zhou, S. A. Woodhouse, P. B. Schiff, P. Zhang, K. S
Outcomes of Primary Squamous Cell Carcinoma of Major Salivary Glands Treated by Surgery With or Without Postoperative Radiotherapy  Lina Wang, MD, Hao.
Lactate-Base 1H Magnetic Spectroscopy Does Not Predict Response and Outcomes in Patients With Stage IV Head and Neck Squamous Cell Carcinoma  Q. Le, A.
Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non–Small Cell Lung Carcinoma Treated With.
Close or Positive Margins After Mastectomy for DCIS: Pattern of Relapse and Potential Indications for Radiotherapy  Afshin Rashtian, M.D., Shawn Iganej,
Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation  Rahul R. Parikh, M.D., Bruce.
The impact of ipsilateral breast tumor recurrence on cause specific survival in DCIS patients treated with breast conserving therapy or mastectomy  C.
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate.
A New Model for Imaging and Radiation Therapy Quality Assurance in the National Clinical Trials Network of the National Cancer Institute  Thomas J. FitzGerald,
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast.
Higher-Than-Conventional Radiation Doses in Localized Prostate Cancer Treatment: A Meta-analysis of Randomized, Controlled Trials  Gustavo Arruda Viani,
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma
International Journal of Radiation Oncology • Biology • Physics
High-Dose-Rate Brachytherapy Boost for Prostate Cancer: Comparison of Two Different Fractionation Schemes  Tania Kaprealian, M.D., Vivian Weinberg, Ph.D.,
Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus  Yang Zhao, MD, ZhiJun Dai,
Radiation Necrosis Mimicking Progressive Brain Metastasis in a Patient with Non-small Cell Lung Cancer  Kadoaki Ohashi, MD, Kastuyuki Kiura, MD, PhD,
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
SC17.02 Lung Cancer in China: Challenges and Perspectives
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients  O. Epaulard, C. Saint-Raymond,
APLCC ORAL ABSTRACT SESSIONS - MONDAY, NOVEMBER 26
Yih-Leong Chang, MD, Chen-Tu Wu, MD, Yung-Chie Lee, MD, PhD 
In This Issue Cell Volume 158, Issue 5, (August 2014)
Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer
Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: A possible association between staining patterns with neuroendocrine markers.
Kavitha K. Reddy  Journal of Investigative Dermatology 
Volume 152, Issue 1, (January 2013)
Jeffrey Bradley, MD, Issam El Naqa, PhD  Journal of Thoracic Oncology 
Randomized Phase II Study of Palifermin for Reducing Dysphagia in Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Unresectable Non-small.
Volume 130, Issue 6, (September 2007)
Correction Journal of the American College of Surgeons
Re-evaluation of the Role of Postoperative Radiotherapy and the Impact of Radiation Dose for Non–Small-Cell Lung Cancer Using the National Cancer Database 
Support Your Specialty
Re-evaluating the Optimal Radiation Dose for Definitive Chemoradiotherapy for Esophageal Squamous Cell Carcinoma  Liru He, MD, Pamela K. Allen, PhD, Adam.
Volume 143, Issue 6, (December 2010)
ALK Translocation in Non-small Cell Lung Cancer with Adenocarcinoma and Squamous Cell Carcinoma Markers  Samuel J. Klempner, MD, David W. Cohen, MD, Daniel.
P3-252: Limited surgery for elderly patients with non-small cell lung cancer who have high risk for lobectomy: Comparison of the short- and the long-term.
Gemcitabine in Brief versus Prolonged Low-Dose Infusion, both Combined with Cisplatin, for Advanced Non-small Cell Lung Cancer: A Randomized Phase II.
Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas?  John M. Varlotto,
A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer  Mian Xi, MD, Zhongxing.
Reviewer Acknowledgment
High Frequency of Radiation Pneumonitis in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Concurrent Radiotherapy and Gemcitabine.
Recursive Partitioning Analysis Groups II–III Brain Metastases of Non-small Cell Lung Cancer: A Phase II Randomized Study Comparing Two Concurrent Chemoradiotherapy.
European Lung Cancer Conference (ELCC) 2016 Organisation
OA Video-Assisted Thoracoscopic Surgery vs
Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.
Neuronatin Expression and Its Clinicopathological Significance in Pulmonary Non-small Cell Carcinoma  Teruhito Uchihara, MD, Chigusa Okubo, MS, Ryota.
PS01.07 The Clinical Necessity of Extended Thymectomy for Thymic Squamous Cell Carcinomas Revealed by Exome Sequencing  J. Jiang, Y. Zhang, C. Jin, J.
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Volume 163, Issue 4, (November 2015)
“The more things change…”: The challenges ahead
Kiran H. Lagisetty, David G. Beer, Andrew C. Chang 
Volume 163, Issue 2, (October 2015)
Journal of Thoracic Oncology
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Impact of Information on Quality of Life and Satisfaction of Non-small Cell Lung Cancer Patients: A Randomized Study of Standardized versus Individualized.
Volume 134, Issue 6, (September 2008)
Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.
In This Issue Cell Volume 145, Issue 3, (April 2011)
Volume 148, Issue 1, (January 2012)
Presentation transcript:

Non-randomized comparison between definitive concurrent chemoradiotherapy and pre- operative radiotherapy followed by surgery in patients with hypopharyngeal squamous cell carcinoma  M. Myojin, M. Nishio, H. Taguchi, M. Takagi, N. Nishiyama, K. Tanaka  International Journal of Radiation Oncology • Biology • Physics  Volume 60, Issue 1, (September 2004) DOI: 10.1016/j.ijrobp.2004.07.449 Copyright © 2004 Terms and Conditions

International Journal of Radiation Oncology • Biology • Physics 2004 60, DOI: (10.1016/j.ijrobp.2004.07.449) Copyright © 2004 Terms and Conditions

International Journal of Radiation Oncology • Biology • Physics 2004 60, DOI: (10.1016/j.ijrobp.2004.07.449) Copyright © 2004 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.